Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes.

Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A, Pierdominici M, Conti F, Truglia S, Siracusano A, Valesini G, Ortona E, Margutti P.

Blood. 2012 Oct 18;120(16):3360-70. doi: 10.1182/blood-2011-09-378851. Epub 2012 Aug 29. Erratum in: Blood. 2014 Jul 24;124(4):662.

2.

Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways.

Xie H, Zhou H, Wang H, Chen D, Xia L, Wang T, Yan J.

Mol Immunol. 2013 Mar;53(3):246-54. doi: 10.1016/j.molimm.2012.08.012. Epub 2012 Sep 8.

PMID:
22964479
3.

Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts.

Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, Conti F, Buttari B, Riganò R, Ortona E, Valesini G.

Arthritis Rheum. 2007 Aug;56(8):2687-97.

4.

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.

Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, Meroni PL.

Blood. 2003 May 1;101(9):3495-500. Epub 2003 Jan 16.

5.

A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.

Allen KL, Fonseca FV, Betapudi V, Willard B, Zhang J, McCrae KR.

Blood. 2012 Jan 19;119(3):884-93. doi: 10.1182/blood-2011-03-344671. Epub 2011 Nov 21.

6.

Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.

Zhou H, Sheng L, Wang H, Xie H, Mu Y, Wang T, Yan J.

Thromb Res. 2013;132(6):742-9. doi: 10.1016/j.thromres.2013.09.039. Epub 2013 Oct 12.

PMID:
24157085
7.

TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.

Xie H, Kong X, Zhou H, Xie Y, Sheng L, Wang T, Xia L, Yan J.

Clin Immunol. 2015 Oct;160(2):198-210. doi: 10.1016/j.clim.2015.05.017. Epub 2015 Jun 9.

PMID:
26065621
8.

β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.

Raschi E, Chighizola CB, Grossi C, Ronda N, Gatti R, Meroni PL, Borghi MO.

J Autoimmun. 2014 Dec;55:42-50. doi: 10.1016/j.jaut.2014.03.001. Epub 2014 Mar 27.

PMID:
24685231
9.

Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.

Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.

Am J Clin Pathol. 2004 Mar;121(3):426-36.

PMID:
15023048
10.

Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.

Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G.

Clin Exp Immunol. 2005 Apr;140(1):173-80.

11.

Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells.

Zhou H, Chen D, Xie H, Xia L, Wang T, Yuan W, Yan J.

Thromb Res. 2012 Oct;130(4):e229-35. doi: 10.1016/j.thromres.2012.08.303. Epub 2012 Aug 30.

PMID:
22940059
12.

The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.

Cucnik S, Kveder T, Ulcova-Gallova Z, Swadzba J, Musial J, Valesini G, Avcin T, Rozman B, Bozic B.

Lupus. 2011 Oct;20(11):1166-71. doi: 10.1177/0961203311406308. Epub 2011 Jun 28. Erratum in: Lupus. 2011 Dec;20(14):1569. Ulcova, G Z [corrected to Ulcova-Gallova, Z].

PMID:
21712304
13.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
14.

[Fine specificity of anti-β2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1].

Nalli C, Andreoli L, Motta M, Norman GL, Shums Z, Binder WL, Nuzzo M, Frassi M, Lojacono A, Meini A, Medeghini V, Avcin T, Meroni PL, Tincani A.

Reumatismo. 2011;63(2):91-6. Italian.

15.

Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome.

Čučnik S, Kveder T, Artenjak A, Ulcova Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Alessandri C, Valesini G, Avčin T, Cohen Tervaert JW, Rozman B, Božič B.

Lupus. 2012 Jun;21(7):764-5. doi: 10.1177/0961203312440057.

PMID:
22635226
17.
18.

Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.

Yasuda S, Bohgaki M, Atsumi T, Koike T.

Immunobiology. 2005;210(10):775-80. Epub 2005 Oct 21. Review.

PMID:
16325497
19.

Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression.

Conti F, Sorice M, Circella A, Alessandri C, Pittoni V, Caronti B, Calderaro C, Griggi T, Misasi R, Valesini G.

Clin Exp Immunol. 2003 Jun;132(3):509-16.

Supplemental Content

Support Center